Frederick Nielsen
Analyst, RedEye
Replay available
Carasent AB (STO: CARA) Q3 2025 earnings conference call, held 2025-10-16. Replay captured from the company's public earnings webcast.

Analyst, RedEye
Good morning and welcome to our presentation of the third quarter We will start with me giving a general update, and then Sven-Martin will continue with the financial update. First, just a quick overview of the business. As you all know, we are a fast-growing SaaS company focused on healthcare and especially HR systems. We have 16% organic ARR growth in a quarter, more than 90% recurring revenue, and a net revenue retention of 111%. looking a bit on the highlights of the third quarter we have really good improvements i think and roughly according to plan and i'm especially happy about the a bit the ac improvement from minus 2.2 million q3 last year to 12.2 million this year and this is based on continued growth and and good cost control and we just continue to to run the business that way um Looking at WebDoc in the quarter, when we were working on their price models and also implementing a new CRM system, we were not totally happy with the old one. We identified a few customers that we invoiced the wrong way and that we have corrected. So it's a hit of roughly one million in the quarter and on an annualized basis. it will hit us roughly by 2 million each year. And it's never fun to take a step down in the recurring revenue. But what's more important for us is good long-term customer relations and good reputation that we continue to sell on. So it's a one-time hit, and all is good with those customers now. So we're in a good place with them, and that's the most important part. What I find really fun at this point in time is that we have very many long development projects that are now reaching the market. And I'll come back to that on the next slide. Looking now at Q4, it would be really important that we succeed with two implementation projects. The first one is Evo...